Clinical trials
Completed Huntington Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 4 |
| CHDI Foundation, Inc. | 3 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 3 |
| Neurocrine Biosciences | 2 |
| Prilenia | 2 |
| Supernus Pharmaceuticals, Inc. | 2 |
| Amarin Neuroscience Ltd | 1 |
| Auspex Pharmaceuticals, Inc. | 1 |
| Huntington Study Group | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huntington Disease | 28 |
| Chorea | 4 |
| Cognitive Dysfunction | 1 |
| Lymphoma, Follicular | 1 |
| Movement Disorders | 1 |
| Neurodegenerative Diseases | 1 |
| Prodromal Symptoms | 1 |
| Rare Diseases | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.